Treatment of diabetic autonomic neuropathy;Tratamiento de la neuropatía autonómica diabética

FMC Formacion Medica Continuada en Atencion Primaria

Volumn 12, Issue 9, 2005, Pages 618-630

  Ortega Millan C ^a  

^a Centro de Salud de Occidente   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 63349087758     PISSN: 11342072     EISSN: 15789675     Source Type: Journal    
DOI: 10.1016/S1134-2072(05)71266-4     Document Type: Article

References (105)

1. H. García-Inerárity, J.C. Romero-Mestre, L. Gómez-Fernández, R. Mustelier-Béquer, and G. Torres-Govin Neuropatía autonómica y neuropatía somática en el paciente diabético: análisis electroclínico Rev Neurol 29 1999 1138 1141
2. The Diabetes Control and Complications Trial Research Group The Effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 1993 977 986
3. The Diabetes Control and Complications Trial Research Group The Effect of intensive diabetes therapy on the development and progression of neuropathy Ann Intern Med 122 1995 561 568
4. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes Lancet 352 1998 837 853 (Pubitemid 28416718)
5. J.E. Shaw, and P.Z. Zimmet The epidemiology of diabetic neuropathy Diabetes Rev 7 1999 245 252
6. J. Rollo Cases of diabetes mellitus 1798 Dilly London
7. M. De Calvi Recherches sur les accidents diabetiques 1864 Asselin Paris
8. J. Althaus On sclerosis of the spinal cord, including locomotot ataxy, spastic spinal paralysis and other system diseases of the spinal cord Their pathology, symptoms, diagnosis, and treatment 1885 Green & Company London
9. M.B. Auche Des alterations des nerfs périphériques Arch Med Exp Anat Pathol 2 1890 635
10. F. Buzzard Illustrations of some less known forms of peripherical neuritis, especially alcoholic monoplegia and diabetic neuritis BMJ 1 1890 1419
11. M. Charcot Sur un cas de paraplégie diabetique Arch Neurol 19 1890 318
12. J.C. Arezzo New developments in the diagnosis of diabetic neuropathy Am J Med 107 1999 S9 S16
13. P.J. Dyck, K.M. Kratz, J.L. Karnes, W.J. Litchy, R. Klein, and J.M. Pach The prevalence by staged severity of various types of diabetic neuropathy,retinopathy, and nephropathy in a population-based cohort: theRochester Diabetic Neuropathy Study Neurology 43 1993 817 824 (Pubitemid 23121981)
14. J. Pirart Diabetes mellitus and its degenerative complications: a prospectivestudy of 4,400 patients observed between 1947 and 1973. Part2 Diabetes Care 1 1978 252
15. S.E. Fagerberg Diabetic neuropathy: a clinical and histological studyon the significance of vascular affections Acta Med Scand 164 Suppl 345 1959 1 97
16. M.J. Young, A.J. Boulton, A.F. MacLeod, D.R. Williams, and P.H. Sonksen Amulticentre study of the prevalence of diabetic peripheral neuropathyin the United Kingdom hospital clinic population Diabetologia 36 1993 150 154
17. A.I. Vinik, M.T. Holland, J.M. Le Beau, F.J. Liuzzi, K.B. Stansberry, and L.B. Colen Diabetic neuropathies Diabetologia 43 2000 957 973
18. A.I. Vinik, and T. Erbas Recognizing and treating diabetic autonomic neuropathy Cleve Clin J Med 68 2001 928 944 (Pubitemid 33100706)
19. P.J. Dyck, W.J. Litchy, K.A. Lehman, J.L. Hokanson, P.A. Low, and P.C. O'Brien Variables influencing neuropathic endpoints: the Rochester DiabeticNeuropathy Study of Healthy Subjects Neurology 45 1995 1115 1121
20. R.E. Maser, A.R. Steenkiste, J.S. Dorman, V.K. Nielsen, E.B Bass, and Q. Manjoo, et al. Epidemiological correlates of diabetic neuropathy. Reportfrom Pittsburgh Epidemiology of Diabetes Complications Study Diabetes 38 1989 1456 1461
21. S. Tesfaye, R. Malik, and J.D. Ward Vascular risk factors and diabetic neuropathy N Engl J Med 352 2005 341 350
22. D. Ziegler, F.A. Gries, M. Spuler, and F. Lessmann The epidemiology ofdiabetic neuropathy. Diabetic Cardiovascular Autonomic NeuropathyMulticenter Study Group J Diabetes Complications 6 1992 49 57
23. D.J. Ewing, I.W. Campbell, and B.F. Clarke Mortality in diabetic autonomicneuropathy Lancet 1 1976 601 603
24. D.J. Ewing, O. Boland, J.M. Neilson, C.G. Cho, and B.F. Clarke Autonomicneuropathy, QT interval lengthening, and unexpected deaths in malediabetic patients Diabetologia 34 1991 182 185
25. D.J. Ewing Diabetic autonomic neuropathy and the heart Diabetes ResClin Pract 30 Suppl 1996 31 36 (Pubitemid 126352574)
26. D. Ziegler, K. Dannehl, H. Muhlen, M. Spuler, and F.A. Gries Prevalence ofcardiovascular autonomic dysfunction assessed by spectral analysis,vector analysis, and standard tests of heart rate variation and bloodpressure responses at various stages of diabetic neuropathy Diabet Med 9 1992 806 814
27. R.E. Maser, M.A. Pfeifer, J.S. Dorman, L.H. Kuller, D.J. Becker, and T.J. Orchard Diabetic autonomic neuropathy and cardiovascular risk. PittsburghEpidemiology of Diabetes Complications Study III Arch Intern Med 150 1990 1218 1222
28. K.Y. Forrest, R.E. Maser, G. Pambianco, D.J. Becker, and T.J. Orchard Hypertensionas a risk factor for diabetic neuropathy: a prospective study Diabetes 46 1997 665 670 (Pubitemid 27143385)
29. M.L. Sands, S.M. Shetterly, G.M. Franklin, and R.F. Hamman Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study Diabetes Care 20 1997 322 329
30. D.A. Greene, M.J. Stevens, I. Obrosova, and E.L. Feldman Glucose-inducedoxidative stress and programmed cell death in diabetic neuropathy Eur J Pharmacol 375 1999 217 223 (Pubitemid 29317606)
31. H. Yasuda, R. Kikkawa, I. Hatanaka, N. Kobayashi, Y. Taniguchi, and Y. Shigeta Skin biopsy as a beneficial procedure for morphological evaluationof diabetic neuropathy Acta Pathol Jpn 35 1985 1 8
32. S.L. Abbate, M.B. Atkinson, and A.C. Breuer Amount and speed of fast axonaltransport in diabetes Diabetes 40 1991 111 117
33. S. Kilo, M. Berghoff, M. Hilz, and R. Freeman Neural and endothelial controlof the microcirculation in diabetic peripheral neuropathy Neurology 54 2000 1246 1252 (Pubitemid 30174042)
34. R.A. Malik, S. Kumar, and A.J. Boulton Mendenhall's syndrome: clues tothe aetiology of human diabetic neuropathy J Neurol Neurosurg Psychiatry 58 1995 493 495
35. N.E. Cameron, and M.A. Cotter Metabolic and vascular factors in the pathogenesisof diabetic neuropathy Diabetes 46 Suppl 2 1997 S31 37
36. P.J. Oates Polyol pathway and diabetic peripheral neuropathy Int RevNeurobiol 50 2002 325 392
37. M.J. Stevens Nitric oxide as a potential bridge between the metabolicand vascular hypotheses of diabetic neuropathy Diabet Med 12 1995 292 295
38. P.J. Dyck, J. Karnes, and P.C. O'Brien Diagnosis, staging, and classificationof diabetic neuropathy and association with other classifications P.J. Dyck, Diabetic neuropathy 1987 WB Saunders Philadelphia
39. a ed. 1993 WB Saunders Philadelphia
40. P.J. Dyck, and C. Giannini Pathologic alterations in the diabetic neuropathiesof humans: a review J Neuropathol Exp Neurol 55 1996 1181 1193 (Pubitemid 26397137)
41. Consensus Statement. Report and Recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association, American Academy of Neurology. Diabetes Care. 1988;11:592-7.
42. American Diabetes Association and American Academic of Neurology. Proceedings of a Consensus Development Conference on Standardized Measures in Diabetic Neuropathy. Diabetes Care. 1992;15: 1080-107.
43. F. Bellavere, M. Ferri, L. Guarini, G. Bax, A. Piccoli, and C. Cardone, et al. Prolonged QT period in diabetic autonomic neuropathy: a possible rolein sudden cardiac death? Br Heart J 59 1988 379 383
44. R.W. Nesto, and R.T. Phillips Asymptomatic myocardial ischemia in diabeticpatients Am J Med 80 1986 40 47
45. R.E. Maser, E. Raelene, D. Mitchell Braxton, I. Vinik Aaron, and R. Freeman The Association between cardiovascular autonomic neuropathy andmortality in individuals with diabetes: a meta-analysis Diabetes Care 26 2003 1895 1901 (Pubitemid 36929140)
46. D. Ziegler Cardiovascular autonomic neuropathy. Clinical manifestationsand measurement Diabetes Rev 7 1999 342 357 (Pubitemid 30072315)
47. M. Pfeifer Valoración cardiovascular P.J. Dyck, P.K. Thomas, Neuropatía diabética 2000 McGraw-Hill InteramericanaEditores Philadelphia 182 195
48. American Heart Association AHA Scientific Statement. Diabetes andcardiovascular disease Circulation 100 1999 1146
49. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus The AACE Systemof Intensive Diabetes Self-management-2000 Update Endocrine Practice 6 2000 43 84
50. P.A. Low Diabetic autonomic neuropathy Semin Neurol 16 1996 143 151
51. D. Robertson, C. Beck, T. Gary, and M. Picklo Classification of autonomicdisorders Int Angiol 12 1993 993 1002
52. A.l. Vinik, and S. Suwanwalaikorn Autonomic neuropathy R.M. DeFronzo, Current therapy of diabetes mellitus 1997 Yearbook New York 165 176
53. M. Feldman, and L.R. Schiller Disorders of gastrointestinal motility associatedwith diabetes mellitus Ann Intern Med 98 1983 378
54. P. Dandona, V. Fonseca, and A. Mier, et al. Diarrhea and metformin in adiabetic clinic Diabetes Care 6 1983 472
55. E. Epanomeritakis, E. Ganotakis, P. Koutsoumbi, I. Tsiaoussis, J.S. Vassilakis, and M. Vlata Impairment of anorectal function in diabetesmellitus parallels duration of disease Dis Colon Rectum 42 1999 1394 1400 (Pubitemid 29532082)
56. M.A. Valdovinos, M. Camilleri, and B.R. Zimmerman Chronic diarrhea indiabetes mellitus: mechanisms and an approach to diagnosis and treatment Mayo Clin Proc 68 1993 691 702
57. M.S. Badiga, N.K. Jain, C. Casanova, and C.S. Pitchumoni Diarrhea in diabetics:the role of sorbitol J Am Coll Nutr 9 1990 578 582
58. K.L. Jones, A. Russo, J.E. Stevens, J.M. Wishart, M.K. Berry, and M. Horowitz Predictors of delayed gastric emptying in diabetes Diabetes Care 24 2001 1264 1269
59. M. Ellenberg Development of urinary bladder dysfunctionin diabetesmellitus Ann Intern Med 1980 321 333
60. P. Enzlin, C. Mathieu, A. Van Den Bruel, J. Bosteels, D. Vanderschueren, and K. Demyttenaere Sexual dysfunction in women with type 1 diabetes:a controlled study Diabetes Care 25 2002 672 677
61. P. Enzlin, C. Mathieu, A. Van Den Bruel, D. Vanderschueren, and K. Demyttenaere Prevalence and predictors of sexual dysfunction in patientswith type 1 diabetes Diabetes Care 26 2003 409 414
62. D.K. McCulloch, I.W. Campbell, F.C. Wu, R.J. Prescott, and B.F. Clarke Theprevalence of diabetic impotence Diabetologia 18 1980 279 283
63. D.K. McCulloch, R.J. Young, R.J. Prescott, I.W. Campbell, and B.F. Clarke The naturalhistory of impotence in diabetic men Diabetologia 26 1984 437 440
64. S. Nakanishi, K. Yamane, N. Kamei, M. Okubo, and N. Kohno Erectile dysfunctionis strongly linked with decreased libido in diabetic men Aging Male 7 2004 113 119
65. R. Quadri, M. Veglio, D. Flecchia, L. Tonda, F. De Lorenzo, and L. Chiandussi Autonomic neuropathy and sexual impotence in diabetic patients:analysis of cardiovascular reflexes Andrologia 21 1989 346 352
66. K. Sarica, et al. Multidisciplinary evaluation of diabetic impotence Eur Urol 26 1994 314 318
67. Z. Colakoglu, E. Kutluay, C. Ertekin, B. Altay, R. Killi, and A. Alkis Autonomicnerve involvement and venous leakage in diabetic men withimpotence BJU Int 83 1999 453 456
68. Y. Takahashi, and Y. Iwamoto Sexual dysfunction in diabetes mellitus Nippon Rinsho 55 1997 2991 2995
69. H. Zheng, G. Li, W. Fan, X. Zhang, S. Chen, and J. Wang The etiology ofimpotence in 327 diabetic male adults. Zhonghua Nei Ke Za Zhi 38 1999 546 549
70. G. De Berardis, F. Pellegrini, M. Franciosi, M. Belfiglio, B. Di Nardo, and S. Greenfield Identifying patients with type 2 diabetes with a higherlikelihood of erectile dysfunction: the role of the interaction betweenclinical and psychological factors J Urol 169 2003 1422 1428
71. X. Navarro, W.R. Kennedy, and T.J. Fries Small nerve fiber dysfunction indiabetic neuropathy Muscle Nerve 12 1989 498 507
72. R.D. Fealey, P.A. Low, and J.E. Thomas Thermoregulatory sweating abnormalitiesin diabetes mellitus Mayo Clin Proc 64 1989 617 628
73. M.J. Young, A. Marshall, J.E. Adams, P.L. Selby, and A.J. Boulton Osteopenia,neurological dysfunction, and the development of Charcot neuroarthropathy Diabetes Care 18 1995 34 38
74. P.E. Cryer Adrenomedullary hypofunction and diabetic neuropathy Ann Neurol 25 1989 418 419
75. S.A. Smith, and S.E. Smith Valoración de la función pupilar P.J. Dyck, P.K. Thomas, Neuropatía diabética 2000 McGraw-HillInteramericana Editores Philadelphia 196 2002
76. M.A. Pfeifer, C.R. Weinberg, and D.L. Cook, et al. Autonomic neural dysfunctionin recently diagnosed diabetic subjects Diabetes Care 7 1984 447 455
77. The St Thomas's Diabetic Study Group Failure of improved glycaemiccontrol to reverse diabetic autonomic neuropathy Diabet Med 3 1986 330 334
78. A. Vinik, T. Erbas, and K. Stansberry Gastrointestinal, genitourinary, andneurovascular disturbances in diabetes Diabet Rev 7 1999 358 378
79. I.W. Campbell, R.C. Heading, P. Tothill, T.A. Buist, D.J. Ewing, and B.F. Clarke Gastric emptying in diabetic autonomic neuropathy Gut 18 1977 462 467
80. D. Patterson A doble blind multicenter comparison of domperidoneand metoclopramide in the treatment of diabetic patients with syntomsof gastroparesis Am J Gastroenterology 94 1999 1230 1234
81. T. Erbas, E. Varoglu, B. Erbas, G. Tastekin, and S. Akalin Comparison ofmetoclopramide and erythromycin in the treatment of diabetic gastroparesis Diabetes Care 16 1993 1511 1514
82. J. Janssens, T.L. Peeters, and G. Vantrappen, et al. Improvement of gastricemptying in diabetic gastroparesis by erythromycin N Engl J Med 322 1990 1028 1031
83. W.D. Bernard, R.D. Lander, and J.O. Covinsky Hypertension caused by clonidinein patients with diabetic autonomic neuropathy Drug IntellClin Pharm 21 1987 546 547
84. A.I. Vinik, and A. Mehrabyan Diagnosis and management of diabetic autonomicneuropathy Compr Ther 29 2003 130 145
85. A.I. Vinik Diabetic neuropathy: pathogenesis and therapy Am J Med 107 1999 S17 26
86. G.N. Verne, and C.A. Sninsky Diabetes and the gastrointestinal tract GastroenterologyClin 27 1998 861 874
87. A.I. Vinik, R.E. Maser, B.D. Mitchell, and R. Freeman Diabetic autonomicneuropathy Diabetes Care 26 2003 1553 1579
88. M. Von der Ohe, M. Camilleri, G.M. Thomforde, and G.G. Klee Differentialregional effects of octreotide on human gastrointestinal motor function Gut 36 1995 743 748
89. W.D. Buser, and P.B. Miner Delayed rectal sensation with fecal incontinence.Successful treatment using anorectal manometry Gastroenterology 91 1986 1186 1191
90. P. Gaede, P. Vedel, H.H. Parving, and O. Pedersen Intensified multifactorialintervention in patients with type 2 diabetes mellitus and microalbuminuria:the Steno type 2 randomised study Lancet 353 1999 617 622
91. D. Ziegler, M. Reljanovic, H. Mehnert, and F.A. Gries Alpha-lipoic acid inthe treatment of diabetic polyneuropathy in Germany: current evidencefrom clinical trials Exp Clin Endocrinol Diabetes 107 1999 421 430
92. A.G. Kontopoulos, V.G. Athyros, T.P. Didangelos, A.A. Papageorgiou, M.J. Avramidis, and M.C. Mayroudi, et al. Effect of chronic quinapril administrationon heart rate variability in patients with diabetic autonomicneuropathy Diabetes Care 20 1997 355 361
93. R.A. Malik, S. Williamson, C. Abbott, A.L. Carrington, J. Iqbal, and W. Schady, et al. Effect of angiotensin-converting-enzyme (ACE) inhibitortrandolapril on human diabetic neuropathy: randomised double-blindcontrolled trial Lancet 352 1998 1978 1981
94. I.W. Campbell, D.J. Ewing, and B.F. Clarke 9-alpha-fluorohydrocortisone inthe treatment of postural hypotension in diabetic autonomic neuropathy Diabetes 24 1975 381 384
95. A. Basso, L. Dalla Paola, G. Erle, M. Boscaro, and D. Armanini Licoriceameliorates postural hypotension caused by diabetic autonomic neuropathy Diabetes Care 17 1994 1356
96. P. Herbison, J. Hay-Smith, G. Ellis, and K. Moore Effectiveness of anticholinergicdrugs compared with placebo in the treatment of overactivebladder: systematic review BMJ 326 2003 841 844
97. M.J. Hilz Erectile dysfunction. An important manifestation of autonomicdiabetic neuropathy MMW Fortschr Med 144 2002 41 44
98. C. Arauz-Pacheco, M. Basco, L.C. Ramírez, J.M. Pita, L. Pruneda, and P.C. Raskin Treatment of diabetic impotence with a vacuum device: efficacyand effects on psychological status Am J Med Sci 303 1992 281 284
99. I. Goldstein, J.M. Young, J. Fischer, K. Bangerter, T. Segerson, and T. Taylor Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatmentof erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study Diabetes Care 26 2003 777 783
100. I. Saenz de Tejada, G. Anglin, J.R. Knight, and J.T. Emmick Effects of tadalafilon erectile dysfunction in men with diabetes Diabetes Care 25 2005 2159 2164
101. J.E. Shaw, R. Parker, S. Hollis, R. Gokal, and A.J. Boulton Gustatory sweatingin diabetes mellitus Diabet Med 13 1996 1033 1037
102. S. Lacigova, Z. Rusavy, D. Cechurova, Z. Jankovec, and M. Zourek Autonomicneuropathy in diabetics, treatment possibilities Vnitr Lek 48 2002 534 541
103. J.M. Brogard, F. Caro-Sampara, and J.F. Blickle Role of polyols in the developmentof diabetic complications. Value of aldose-reductase inhibitors Rev Med Interne 13 1992 69 79
104. I.G. Obrosova, C Van Huysen, L. Fathallah, X.C. Cao, D.A. Greene, and M.J. Stevens An aldose reductase inhibitor reverses early diabetes- inducedchanges in peripheral nerve function, metabolism, and antioxidativedefense FASEB J 16 2002 123 125
105. L. Packer, H.J. Tritschler, and K. Wessel Neuroprotection by the metabolicantioxidant alpha-lipoic acid Free Radic Biol Med 22 1997 359 378